Scholars Central

Conference abstractPublished 12 Sep 2011

Development and prospective evaluation of a 20-gene model for molecular nodal staging of bladder cancer

Authors: Alexander Baras

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Neoadjuvant chemotherapy prior to cystectomy confers a small yet signifi cant survival benefi t in bladder cancer. Yet, it has not been widely adopted, since most patients do not benefi t and we are currently unable to predict those that do. We propose that tools identifying patients with advanced disease prior to surgical management would be useful in selecting patients for neoadjuvant chemotherapy. Methods: We developed a gene expression model (GEM) predictive of pathological node status for use on primary tumor tissue from clinically node negative (cN0) patients. From a subset of transcripts, we developed both the GEM and cutoff s identifying patient strata with elevated and decreased risk of nodal involvement using two separate training cohorts (N=90 and N=66). We then independently evaluated the GEM and cutoff s to predict node positive disease in tissues from a Phase III trial cohort (AUO-AB-05/95, N=185). Findings: A 20-gene GEM was developed and the stratifi cation schema from it identifi ed subjects with high (RR 1.74, [1.03-2.93]) and low (RR 0.70, [0.51-0.96]) relative risk of node positive disease. Multivariate logistic regression demonstrated the GEM predictor was independent of age, gender, pathologic stage, and lymphovascular space invasion (P=0.019). Interpretations: Th is study proves the principle that molecular staging before surgery can be faithfully achieved and could change the way we view urothelial cancer management and practice. Selecting patients for neoadjuvant chemotherapy based on the risk of node positive disease has the potential to benefi t high-risk patients while sparing others toxicity and delay to cystectomy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Biomarkers & Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Biomarkers & Diagnosis
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Alexander Baras”